Brief: Spyre Therapeutics Says Co Got Approval From Nasdaq Staff To Transfer Listing Of Common Stock From Nasdaq Capital Market To Nasdaq Global Select Market
18/01/2024 23:22
Jan 18 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* SPYRE THERAPEUTICS-ON JAN 16 GOT APPROVAL FROM NASDAQ
STAFF TO
TRANSFER LISTING OF COMMON STOCK FROM NASDAQ CAPITAL MARKET TO
NASDAQ GLOBAL SELECT MARKET
* SPYRE THERAPEUTICS INC - TRANSFER OF STOCK TO NASDAQ
GLOBAL
SELECT MARKET, EFFECTIVE AS OF OPENING OF BUSINESS ON JANUARY
19, 2024
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock